Cathepsin K activity-dependent regulation of osteoclast actin ring formation and bone resorption.
about
MicroRNAs in Osteoclastogenesis and Function: Potential Therapeutic Targets for OsteoporosisBaicalin positively regulates osteoclast function by activating MAPK/Mitf signalling.Effects of ω3- and ω6-polyunsaturated fatty acids on RANKL-induced osteoclast differentiation of RAW264.7 cells: a comparative in vitro study.Emerging therapies in metastatic bone pain.Inositol hexakisphosphate inhibits osteoclastogenesis on RAW 264.7 cells and human primary osteoclasts.Potential role of cathepsin K in the pathophysiology of mucopolysaccharidoses.Inhibition of osteoclast differentiation and bone resorption by N-methylpyrrolidoneType I saikosaponins a and d inhibit osteoclastogenesis in bone marrow-derived macrophages and osteolytic activity of metastatic breast cancer cellsCXCL8 and CCL20 Enhance Osteoclastogenesis via Modulation of Cytokine Production by Human Primary Osteoblasts.Rosmarinic acid and arbutin suppress osteoclast differentiation by inhibiting superoxide and NFATc1 downregulation in RAW 264.7 cellsAccelerated Lactate Dehydrogenase Activity Potentiates Osteoclastogenesis via NFATc1 Signaling.WSS25, a sulfated polysaccharide, inhibits RANKL-induced mouse osteoclast formation by blocking SMAD/ID1 signaling.Ethanolic extract of Schizonepeta tenuifolia attenuates osteoclast formation and activation in vitro and protects against lipopolysaccharide-induced bone loss in vivo.Inhibition of Osteoclastogenesis and Bone Resorption in vitro and in vivo by a prenylflavonoid xanthohumol from hopsCurcumin improves bone microarchitecture in glucocorticoid-induced secondary osteoporosis mice through the activation of microRNA-365 via regulating MMP-9.Regulators of G protein signaling 12 promotes osteoclastogenesis in bone remodeling and pathological bone loss.The 1,2,3-triazole derivative KP-A021 suppresses osteoclast differentiation and function by inhibiting RANKL-mediated MEK-ERK signaling pathway.Pathobiology and management of prostate cancer-induced bone pain: recent insights and future treatments.Wedelolactone enhances osteoblastogenesis by regulating Wnt/β-catenin signaling pathway but suppresses osteoclastogenesis by NF-κB/c-fos/NFATc1 pathwayGlycosaminoglycan-mediated loss of cathepsin K collagenolytic activity in MPS I contributes to osteoclast and growth plate abnormalities.Macrophage cathepsin K promotes prostate tumor progression in bone.Emerging therapeutic targets in breast cancer bone metastasis.Classical and neonatal Marfan syndrome mutations in fibrillin-1 cause differential protease susceptibilities and protein function.Impaired osteoclast homeostasis in the cystatin B-deficient mouse model of progressive myoclonus epilepsy.Epithelium-Derived Wnt Ligands Are Essential for Maintenance of Underlying Digit Bone.Ferulic acid impairs osteoclast fusion and exacerbates survival of mature osteoclasts.The Beneficial Effect of Praeruptorin C on Osteoporotic Bone in Ovariectomized Mice via Suppression of Osteoclast Formation and Bone Resorption.Nardosinone Suppresses RANKL-Induced Osteoclastogenesis and Attenuates Lipopolysaccharide-Induced Alveolar Bone Resorption.Magnesium vs. machined surfaced titanium - osteoblast and osteoclast differentiation.Osteoblast Hypoxia-Inducible Factor-1α Pathway Activation Restrains Osteoclastogenesis via the Interleukin-33-MicroRNA-34a-Notch1 Pathway.The Inactivation of ERK1/2, p38 and NF-kB Is Involved in the Down-Regulation of Osteoclastogenesis and Function by A2B Adenosine Receptor Stimulation.Lithium chloride inhibits titanium particle-induced osteoclastogenesis by inhibiting the NF-κB pathway.Dihydromyricetin Protects against Bone Loss in Ovariectomized Mice by Suppressing Osteoclast Activity.Sophocarpine attenuates wear particle-induced implant loosening by inhibiting osteoclastogenesis and bone resorption via suppression of the NF-κB signaling pathway in a rat model.Inhibitory effects of sesamin on human osteoclastogenesis.The Inhibitory Effect of Angelica tenuissima Water Extract on Receptor Activator of Nuclear Factor-Kappa-B Ligand-Induced Osteoclast Differentiation and Bone Resorbing Activity of Mature Osteoclasts.Liensinine and Nuciferine, Bioactive Components of Nelumbo nucifera, Inhibit the Growth of Breast Cancer Cells and Breast Cancer-Associated Bone Loss.Double Sequential Encrypted Targeting Sequence: A New Concept for Bone Cancer Treatment.Systemic administration of omeprazole interferes with bone healing and implant osseointegration: an in vivo study on rat tibiae.Expression of typical osteoclast markers by PBMCs after PEG-induced fusion as a model for studying osteoclast differentiation.
P2860
Q26752588-392E19AC-E345-45C6-995F-45CD85029EFEQ33844646-53CB6535-66D3-43EA-A79D-C99B9B3EB8A3Q33963239-8F00FACB-B3A2-45D9-AADA-31987FD89E4CQ34182919-C8EE2BEC-3679-456B-B600-ACDD8C70E205Q34384846-6580A5DB-6A19-41D2-802F-BF4F6ACE679DQ35012589-98F743AF-4004-4A9E-9201-22F9ED2FBEF9Q35085185-AF6AADE7-D56C-43A6-B501-2CC92B923525Q35373142-84B6D015-9CF9-4610-A987-DDC18FD4068CQ35672086-03FB5C49-2C7E-4CD7-AF33-29E544928784Q35803432-1F95048C-E3AD-438B-91FC-2905EA7616EAQ35989618-39613EBA-9223-4209-9A14-C418E5AE1C53Q36034275-1CC40DDC-25CC-408F-85E6-6D6C111E51B2Q36109806-9E9C5AC9-C967-4E01-9B80-8A5C29FD2491Q36333546-FC7D0A09-2AE8-477B-A1FC-49A9B89DFD83Q36511687-B5DB8DFF-60A2-480E-980A-D7C138D0153EQ36751534-9E575EA6-7666-4A04-BA68-43201F4F09E9Q37071329-C00EF118-3B92-4117-A117-519DBABFE29CQ37187646-EF0A7EA5-7D5C-44F0-B5EF-8A524D8A12A0Q37203221-1C9E73AB-BFDA-463E-B802-38669669532AQ37413691-2264C1AE-03FE-453E-B1B4-2082FD1B20E4Q37554550-1DEA361B-6A94-45E1-A462-3E71BCD11142Q37658767-76440B62-8FD9-4400-B71A-849E3D5CD9FBQ38421397-B3D37C68-A9B0-4A0E-BF44-1C3C7C810648Q38854289-BBC3C066-E59C-4ECF-8DF8-A31124240615Q39883776-40439BF3-CFC4-4375-8478-FECCC936FC6AQ41639542-EC77E9B1-CF20-4F91-B121-32914E7E1230Q41684447-74478E8A-24EF-4C29-A080-9A4E18B55DA2Q41684459-08F7A4B7-94B4-458F-B791-B6932EFFACD4Q42723672-32CC558D-D3AB-49F9-A500-37CEC24A41CFQ42937988-E798CA79-5148-42C7-8513-7CA251FA8E8AQ47109047-E98B04AF-55D3-4E56-9D9E-78337FFCE7ACQ47124172-86FDBD4F-0873-4200-ADB4-C8A23717BCEEQ47214335-159418B8-B40A-498C-ACAD-5E0C2A011A83Q47609765-94D22F5B-F751-4E35-AB70-7CAD2778350CQ47730277-9C6BB122-4313-447D-B8CB-6CA7FA6C9F1EQ48079300-1FDD1FB9-43F4-4CC8-ADDC-49C13DA2C1EAQ48247265-8362E49E-604F-4EE9-AD90-2A7E818F87EBQ48824485-87FA236E-8D2D-464A-85B6-D0E5E3DF4E54Q51578494-935BDF6A-E0EB-423E-BCD2-99E029AAF546Q52779703-0B4138A2-3E52-4350-8DB3-A023D9F93986
P2860
Cathepsin K activity-dependent regulation of osteoclast actin ring formation and bone resorption.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Cathepsin K activity-dependent ...... formation and bone resorption.
@en
Cathepsin K activity-dependent ...... formation and bone resorption.
@nl
type
label
Cathepsin K activity-dependent ...... formation and bone resorption.
@en
Cathepsin K activity-dependent ...... formation and bone resorption.
@nl
prefLabel
Cathepsin K activity-dependent ...... formation and bone resorption.
@en
Cathepsin K activity-dependent ...... formation and bone resorption.
@nl
P2093
P2860
P356
P1476
Cathepsin K activity-dependent ...... formation and bone resorption.
@en
P2093
Christoph Peters
Dieter Brömme
Paul Saftig
Susan R Wilson
P2860
P304
P356
10.1074/JBC.M805280200
P407
P577
2008-11-21T00:00:00Z